OptimizeRx (OPRX) Capital Expenditures (QoQ) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -40.35% |
| Mar 31, 2025 | 235.29% |
| Dec 31, 2024 | 125.76% |
| Sep 30, 2024 | -265.00% |
| Jun 30, 2024 | -66.94% |
| Mar 31, 2024 | 108.21% |
| Dec 31, 2023 | -197.49% |
| Sep 30, 2023 | 7,460.00% |
| Jun 30, 2023 | -31.03% |
| Mar 31, 2023 | 77.50% |
| Dec 31, 2022 | -29.98% |
| Sep 30, 2022 | -13.12% |
| Jun 30, 2022 | 85.46% |
| Mar 31, 2022 | -61.65% |
| Dec 31, 2021 | 99.66% |
| Sep 30, 2021 | -20.49% |
| Jun 30, 2021 | 19.69% |
| Mar 31, 2021 | -12.80% |
| Dec 31, 2020 | 12.50% |
| Sep 30, 2020 | 123.55% |
| Jun 30, 2020 | -43.14% |
| Mar 31, 2020 | -39.31% |
| Dec 31, 2019 | 91.43% |
| Sep 30, 2019 | -59.52% |
| Jun 30, 2019 | 144.74% |
| Mar 31, 2019 | 23.30% |
| Dec 31, 2018 | 6.58% |
| Sep 30, 2018 | 19.89% |
| Jun 30, 2018 | 131.13% |
| Mar 31, 2018 | -70.59% |
| Dec 31, 2017 | 174.53% |
| Sep 30, 2017 | -44.27% |
| Jun 30, 2017 | -47.65% |
| Mar 31, 2017 | -82.64% |
| Dec 31, 2016 | 41.78% |
| Sep 30, 2016 | 1,137.42% |
| Jun 30, 2016 | -63.45% |
| Mar 31, 2016 | 837.75% |
| Dec 31, 2014 | 289.29% |
| Jun 30, 2012 | -43.40% |
| Mar 31, 2012 | -89.13% |